ALK GENE MUTATION
Clinical trials for ALK GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ALK GENE MUTATION trials appear
Sign up with your email to follow new studies for ALK GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stall ALK-Positive lung cancer
Disease control OngoingThis phase 2 study tests whether adding chemotherapy to the targeted drug brigatinib helps people with advanced ALK-positive non-small cell lung cancer live longer without their cancer growing. About 110 people who have not had treatment for advanced disease will receive either b…
Matched conditions: ALK GENE MUTATION
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Smartwatch and app aim to track lung cancer symptoms in real time
Knowledge-focused OngoingThis study tests whether a remote monitoring system—including a smartphone app, a Fitbit, and a smart pill cap—can effectively track symptoms and side effects in 30 lung cancer patients taking oral targeted therapy. Participants will use the system for up to 24 weeks, and the goa…
Matched conditions: ALK GENE MUTATION
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC